News

Filter

Current filters:

Stelara InjectionRemicade

Highlights from Digestive Disease Week

11-05-2011

The 2011 Digestive Disease Week meeting in Chicago, USA, heard a number of interesting presentations…

Abbott LaboratoriesDificidGastro-intestinalsJohnson & JohnsonLubiprostoneOptimer PharmaceuticalsPharmaceuticalRemicadeResearchResolorShireStelara InjectionSucampo

FDA further delays J&J's psoriasis drug Stelara, requests more information

12-01-2009

The US Food and Drug Administration has announced further delays for US health care major Johnson & Johnson…

AmgenEnbreletanerceptinfliximabJanssen-CilagJohnson & JohnsonRemicadeSchering PloughSchering-PloughStelara InjectionustekinumabWyeth

J&J psoriasis candidate may cause cancer; FDA

23-06-2008

USA-based Centocor's experimental psoriasis drug, ustekinumab (CNTO 1275) may increase the risk of cancer,…

Amino AcidsinfliximabInjectionJohnson & JohnsonPhysostigmine SalicylateRemicadeStelara Injectionustekinumab

Centocor's psoriasis drug accepted for FDA review

10-03-2008

USA-based Centocor's Biologics License Application for ustekinumab (CNTO 1275) has been accepted for…

AmgenEnbreletanerceptinfliximabJohnson & JohnsonRemicadeSchering PloughSchering-PloughStelara InjectionustekinumabWyeth

Ustekinumab: "gold standard" for psoriasis by 2011

18-02-2008

Following its approval in early 2009, Centocor/Janssen-Cilag's ustekinumab will become the clinical gold…

AmgenEnbreletanerceptinfliximabJanssen-CilagRemicadeSchering PloughSchering-PloughStelara InjectionustekinumabWyeth

COMPANY SPOTLIGHT

Menarini

Back to top